CN111925285A
|
|
Preparation method of 7-phenyl-6-heptynoic acid
|
CN109721552A
|
|
A kind of preparation method of Gefitinib
|
CN109721551A
|
|
A kind of preparation method of 3,4- dihydro -7- methoxyl group -4- oxoquinazolin -6- alcohol acetic ester
|
CN107098905A
|
|
A kind of indoles alkaloid and its production and use
|
CN106565554A
|
|
Preparation method for sulfonyl hydroquinone compound
|
CN106632372A
|
|
Intermediate and preparation method and use thereof
|
CN106478572A
|
|
A kind of Beraprost and its preparation method of salt
|
CN106008526A
|
|
Preparation method of ibrutinib
|
CN106928089A
|
|
A kind of preparation method of MMH
|
CN105503595A
|
|
Preparation method of R-type methyl 2-methyl-hexyl-4-acetylenate
|
CN105585523A
|
|
Novel sorafenib TsOH crystal form as well as preparation method and application thereof
|
CN105801429A
|
|
Preparation method for 3,5,-dichloro-2,4,-difluoroaniline
|
CN104592245A
|
|
Spiroketal derivative and preparation method and application thereof
|
CN104496904A
|
|
Synthesis method of ruxolitinib intermediate
|
CN103833725A
|
|
Method for synthesizing 5-N-tert-butyloxycarbonyl-5-N-methylamino-2-thiophenic acid
|
CN103145720A
|
|
Preparation method of 10-hydroxycamptothecin monohydrate
|
CN102311443A
|
|
Novel crystal form of irinotecan hydrochloride and preparation method thereof
|
CN102070575A
|
|
New synthesis method of caronic anhydride
|
CN102399231A
|
|
Galanthamine preparation method
|
CN101648928A
|
|
Method for purifying taxane compound
|